(Stroke. 1996;27:1770-1773.)
© 1996 American Heart Association, Inc.
Articles |
The Tel Aviv Stroke Registry
3600 Consecutive Patients
the Department of Neurology, Tel Aviv Medical Center, and the Sackler Faculty of Medicine, Tel Aviv University (Israel).
 |
Abstract |
|---|
 Top Abstract IntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Background and Purpose We undertook to estimate the frequency of various risk factors and the type and severity of stroke in different ethnic groups documented in a large hospital-based stroke registry. Tel Aviv is a metropolis with about 400 000 inhabitants and about 600 000 daily visitors and workers. The Tel Aviv Medical Center (TAMC) is the only tertiary medical care facility to which all patients with acute stroke are referred. Israel is a country with a heterogeneous population, of which a significant proportion was born abroad. The people differ in their genetic background, as well as in their early environmental conditions, lifelong diet, and other habits. This variety has proved to be a fertile ground for the study of different neurological diseases, including stroke.
Methods A prospective hospital-based registry using systematic computer coding of data of all consecutive stroke patients admitted to the TAMC has been conducted since May 1988. Different aspects of the amassed data were analyzed statistically.
Results From May 1988 until April 1994, 3600 stroke patients were admitted to the TAMC. The mean age was 73.2 years, and 58.2% were males. Cerebral infarctions were diagnosed in 80.9%, primary intracerebral hemorrhages in 8.0%, and transient ischemic attacks in 11.1%. There were 861 patients (24%) who were admitted with recurrent strokes. Past medical history of hypertension was the major risk factor (occurring in 52.2% of the patients), followed by ischemic heart disease (29.7%), diabetes mellitus (25.2%), smoking (17.0%), atrial fibrillation (14.3%), and hyperlipidemia (8.4%). Ischemic heart disease and atrial fibrillation were more frequent in patients from Europe and America (Ashkenazi group), whereas diabetes mellitus and smoking were more prominent in the other groups. The in-hospital mortality rate was 13.8% and was similar in both ethnic groups.
Conclusions This registry allows the study of the risk factors, natural history, and clinical manifestations of stroke in different ethnic groups.
Key Words: epidemiology • ethnic groups • Israel • registries
|
Introduction |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Reports from various stroke registries have provided wide and extensive analyses of incidence, risk factors, new diagnostic procedures, and mortality.1 2 There are recognized geographic variations in the incidence of and mortality from stroke, and these may provide a key to understanding of risk factors for cerebrovascular diseases. Moreover, the relative importance of different risk factors may vary among countries.
Israel has a heterogeneous population, of which a considerable proportion was born abroad. The people differ in their genetic background, as well as in their early environment, lifelong dietary patterns, and other habits. This country provides unusual opportunities for collecting information, since the medical facilities in Israel are of excellent quality and are equally accessible to all segments of the population, regardless of ethnic origin or socioeconomic status. However, only limited studies of stroke epidemiology in Israel are available.3 4 5
The Tel Aviv Stroke Registry (TASR) was established in 1988 as a prospective study using systematic computer coding of data from all patients admitted with stroke. Using the amassed data, we attempted to estimate the type and severity of stroke, define the profile of risk factors and outcomes, and detect potential differences in stroke profiles in different ethnic groups.
|
Subjects and Methods |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Throughout the 6 years between May 1, 1988, and April 30, 1994, all stroke patients admitted to the Tel Aviv Medical Center (TAMC) were evaluated, examined, and registered by an experienced stroke team consisting of four dedicated and well-trained neurologists. The standard protocol included the demographic data, stroke description (eg, infarct, hemorrhage, transient ischemic attack), stroke distribution (eg, right or left hemisphere, brain stem, cerebellum, unknown), onset (eg, abrupt, gradual, stepwise, stuttering), presence or absence of headache, onset during sleep or wakefulness, and past medical history of vascular risk factors (eg, hypertension, ischemic heart disease, cardiac arrhythmias, congestive heart failure, peripheral vascular disease, diabetes mellitus, hyperlipidemia, smoking). Definitions of the various vascular risk factors are available from the authors.
The definitions of these risk factors are shown in Table 1
. Strokes were divided into three degrees of severity based on activities of daily living: independence in these activities (mild), partial dependence (moderate), and complete dependence (severe). The severity was defined within 24 hours after admission. The patients with subarachnoid hemorrhage were excluded because of the different pathophysiology involved. Interrater agreement for the different items of evaluation was very good, with a high Kendall coefficient of concordance.6
|
The patients were divided into three groups based on country of birth (Europe/America, Asia/Africa, and Israel), and a fourth group was composed of individuals whose birthplace was unknown. Mortality was defined as death occurring before discharge from the hospital (in-hospital mortality). Patients with a suspected diagnosis of stroke underwent a standard protocol of investigations: brain CT in most of the patients, electrocardiography, electroencephalography, and routine blood and urine tests.
The stroke unit also has an active Doppler laboratory with a duplex device and transcranial Doppler operated by well-trained and experienced technicians. Digital subtraction angiography is performed in selected patients.
The patients' current medications were recorded, including antithrombotic drugs. Aspirin failure was defined as recurrence of stroke in patients taking aspirin.
|
Results |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
A total of 3600 consecutive patients with stroke were admitted to the TAMC during the study period. All patients were prospectively coded, and the findings were entered into a computerized data bank.
There were 2094 males (58.2%), and the mean±SD age was 73.2±10.7 years. The age distribution of these patients in relation to the population at risk in different age groups is shown in Table 1
. The difference in age distribution between the TASR patients and the Tel Aviv population at large was significant (P<.01).
CT was performed in 77.3% of the patients, providing a differential diagnosis of hemorrhagic versus ischemic stroke. Cerebral infarctions were diagnosed in 2915 patients (81.0%) and primary intracerebral hemorrhages in 288 (8.0%). Transient ischemic attacks occurred in 397 patients (11.0%).
In terms of various vascular territories, in 1423 patients (39.5%) the stroke occurred in the right hemisphere and in 1608 (44.7%) in the left hemisphere; in 453 (12.6%) the stroke occurred in the vertebrobasilar region, and in 116 (3.2%) the site was unknown. The difference between right and left hemispheres was statistically significant (P<.001; z=-3.29, binomial distribution). In terms of stroke severity, it was mild in 46%, moderate in 17%, and severe in 37%.
The distribution of patients in terms of sex and ethnic origin was similar to that of the Tel Aviv population (Table 2).
|
The frequencies of the various risk factors in the ethnic groups are summarized in Table 3. A past medical history of hypertension was the most prominent factor, recorded in 52.2% (1879) of the patients, followed by diabetes mellitus (25.2%, 908). Ischemic heart disease was present in 29.7% (1069) of the stroke patients: 14.3% (514) of them had atrial fibrillation and 8.3% (299) had congestive heart failure. There were 613 (17.0%) patients with a history of cigarette smoking, and 8.5% (305) had hyperlipidemia.
|
Patients from Europe and America more frequently had ischemic heart disease and atrial fibrillation, whereas diabetes mellitus and smoking were more prevalent in the other groups (Table 3). Table 4 shows data taken from the literature7 8 regarding the odds ratio of risk factors for stroke patients compared with control groups. Of the 3600 stroke patients, 861 (24.0%) were admitted with recurrent strokes (most of them were recurrent ischemic brain events) and 159 (18.5%) had more than one recurrent stroke. Ninety-two of the 861 patients (10.7%) died.
|
Table 5 shows the mortality rates and severity in the TASR. As a whole, with use of the linear trend test, there was no trend toward a decrease in mortality over the years.
|
|
Discussion |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Epidemiological aspects of stroke have been studied in many countries by means of stroke registries,7 8 9 10 11 12 13 14 15 16 17 18 some of which were prospective and population-based9 13 14 16 17 18 19 20 while others were hospital-based.7 10 11 12 Although the Tel Aviv Stroke Registry is a hospital-based registry, it has provided an unusual opportunity to evaluate all the segments of the Israeli population in terms of ethnic groups and origin. A much earlier multicenter study performed with the collaboration of the World Health Organization21 showed that the incidence rates for all types of stroke in Israel are similar to those in several European countries, but they are significantly less than those in Japan and Finland. The reasons for the discrepancy between Israel and other countries can only be speculated on; they apparently include genetic factors, stress, diet, lack of alcoholism, and the nature of the medical services providing treatment of risk factors such as hypertension.
As in previous reports from Israel4 20 22 and other countries,8 10 13 we found that the proportion of males was greater (58.2%), which is in contradiction to the findings of Faulkes et al.11 Headaches associated with the onset of risk were reported in 12.8% of our patients, whereas other registries recorded incidences of 9%7 and 23%.10 The differences could be due to different methods of data collection and varying definitions of headaches.
With stroke being a disorder associated with aging, the difference in age distribution between TASR patients and the general Tel Aviv population, as expected, was significant (P<.001), and the comparative age of the patients with stroke was significantly higher as well.
We noted the significant difference of laterality of the hemispheric stroke: in the left hemisphere it occurred more frequently than stroke in the right hemisphere.
We found the frequencies of the common risk factors for stroke in Israel to be similar to those of the other developed countries,23 24 with significantly higher prevalence of hypertension (52%; Table 3). These results correspond with those of previous studies by other authors.4 5 10 16 25 26 27 28 Earlier comparisons of stroke and risk factor frequencies in each ethnic group with their frequencies in the same ethnic groups in the general population were impossible because of lack of data.29 30 The distribution of the three main Israeli ethnic groups—European/American (Ashkenazi), Asian/African (Sephardic), and native Israeli populations—was registered in the TASR (Table 2). Our analysis of risk factors for stroke among the ethnic groups showed a significant trend toward a high frequency of ischemic heart disease and atrial fibrillation in the European/American group (P<.001), with diabetes mellitus and smoking being more prevalent in the other groups (P<.001). It was suggested that Ashkenazi Jews have a higher frequency of coronary atherosclerosis and therefore are predisposed to have a stroke.
Over the 6 years of the present study, a trend emerged showing a decline of stroke mortality among our stroke patients, a feature that was seen in other analyses of stroke deaths over the last two decades.16 17 18 This parallels the worldwide decline in cardiovascular diseases mortality. Mortality from coronary heart disease underwent a striking decline in Jews,27 with the trend beginning even before the initiation of programs for the control of high blood pressure, hyperlipidemia, and cessation of smoking habits.16 17 18 20 25 26 31 32 33 34
The TASR serves as a data bank, a concept that proved efficacious in providing a method for establishing a valuable clinical research data resource. The TASR has been a source for a series of clinical studies, including dealing with dementia after first-ever stroke,35 failure of aspirin treatment after stroke,36 electroencephalography as a predictor of dementia after first ischemic stroke,37 and others. Thus, the TASR is a source of information for analysis of different aspects of stroke. It provides an opportunity for valuable understanding of the etiology and pathophysiology of different subtypes of stroke, in addition to facilitating the detection of mortality trends and determination of their causes.
|
Footnotes |
|---|
Reprint requests to Dr N.M. Bornstein, Department of Neurology, Tel Aviv Medical Center, 6 Weizmann St, Tel Aviv, 64239, Israel.
Received April 1, 1996; revision received June 20, 1996; accepted June 20, 1996.
|
References |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
1. Bonita R, Beaglehole R. Monitoring stroke: an international challenge. Stroke. 1995;26:541-542.
2.
Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas A-M, Schroll M. Stroke incidence, case fatality, and mortality in the WHO MONICA Project. Stroke. 1995;26:361-367.
3. Yablonski M, Behar A, Ungar H, Resch J, Alter M. Cerebral atherosclerosis among Jews of European and Afro-Asian origin. Neurology. 1968;18:550-558.
4. Adler E, Adler C, Magora A, Shanan J, Tal E. Stroke in Israel 1957-1961: epidemiological, clinical, rehabilitation and psychosocial aspects. Jerusalem, Israel: Polypress; 1969.
5.
Lavy S, Melamed E, Cahane E, Carmon A. Hypertension and diabetes as risk factors in stroke patients. Stroke. 1973;4:751-759.
6. Treves T, Karepov V, Aronovich B, Gorbulev A, Bornstein N, Korczyn AD. Interrater agreement in evaluation of stroke patients with the Unified Neurological Stroke Scale. Stroke. 1994;25:1263-1264.[Abstract]
7.
Mohr JP, Caplan L, Melski J, Goldstein R, Duncan G, Kistler J, Pessin M, Bleich H. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology. 1978;28:754-762.
8.
Reunanen A, Aho K, Aromaa A, Knevet P. Incidence of stroke in a Finnish prospective population study. Stroke. 1986;17:675-681.
9.
Lindenstram E, Boysen G, Nyboe J, Appleyard M. Stroke incidence in Copenhagen, 1976-1988. Stroke. 1992;23:28-32.
10.
Bogousslavsky Y, Van Melle Y, Regli F, for the Lausanne Registry group. The Lausanne Stroke Registry: analysis of 1000 consecutive patients with first stroke. Stroke. 1988;19:1083-1092.
11.
Faulkes M, Wolf P, Price T, Mohr Y, Hier D. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke. 1988;19:547-554.
12.
Sobel E, Alter M, Davanipour Z, Friday Y, McCoy R, Levitt LP, Isack T. Stroke in the Lehigh Valley: combined risk factors for recurrent ischemic stroke. Neurology. 1989;39:669-672.
13.
Wender M, Lenart-Yankowska D, Prochmil D, Kawal P. Epidemiology of stroke in the Posnan District of Poland. Stroke. 1990;21:390-393.
14.
Jerntorp P, Berglund G. Stroke Registry in Malmo, Sweden. Stroke. 1992;23:357-361.
15.
Berginer V, Goldsmith J, Batz U, Vardi H, Shapiro Y. Clustering of stroke in association with meteorologic factors in the Negev Desert of Israel: 1981-1983. Stroke. 1989;20:65-69.
16. Bonita R, Anderson G, Broad J, Jamrozik K, Stewart-Wynne EG. Stroke incidence and case fatality in Australasia. Stroke. 1994;25:552-557.[Abstract]
17. Hong Y, Bots M, Pan X, Hofman A, Grobbee D, Chen H. Stroke incidence and mortality in rural and urban Shanghai from 1984 through 1991: findings from a community-based registry. Stroke. 1994;25:1165-1169.[Abstract]
18. Kagan A, Popper J, Reed D, Maclean C, Grave J. Trends in stroke incidence and mortality in Hawaiian Japanese men. Stroke. 1994;25:1170-1175.[Abstract]
19.
Caplan LR, Gorelick PB, Hier DB. Race, sex, and occlusive cerebrovascular disease: a review. Stroke. 1986;17:648-655.
20.
Epstein L, Rishpon S, Bental E, Brook Y, Tamir A, Gross B, Szwarc M, Manelis Y, Pillar T. Incidence, mortality, and case-fatality rate of stroke in northern Israel. Stroke. 1989;20:725-729.
21. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull WHO. 1980;58:113-130.[Medline] [Order article via Infotrieve]
22.
Melamed E, Cahane E, Caman A, Lavy S. Stroke in the Jerusalem district 1960 through 1967: an epidemiological study. Stroke. 1973;4:465-471.
23. Dyken ML, Wolf PA, Barnett HJM, Beran JJ, Hass WK, Kannel WB, Kuller L, Kurtzke YF, Sundt TM. Risk factors in stroke: a statement for physicians by the subcommittee on risk factors and stroke of the stroke council. Stroke. 1984;15:1105-1111.
24. Wolf P. An overview of the epidemiology of stroke. Stroke. 1990;21(9 Suppl):II-4-II-6.
25.
Wolf PA, D'Agostino RB, O'Neal MA, Sytkowski P, Kase CS, Belanger AY, Kamel WB. Secular trends in stroke incidence and mortality: the Framingham Study. Stroke. 1992;23:1551-1555.
26.
Modan B, Wagener DK. Some epidemiological aspects of stroke: mortality/morbidity trends, age, sex, race, and socioeconomic status. Stroke. 1992;23:1230-1236.
27. Goldbourt U, Neufeld H. Trends in coronary heart disease mortality and related factors in Israel. Cardiology. 1985;72:63-74.[Medline] [Order article via Infotrieve]
28. Dreyfuss F, Hamosh P, Adam Y, Kaliner B. Coronary heart disease and hypertension among Jews who immigrated to Israel from the Atlas mountain regions of North Africa. Am Heart J. 1987;18:28-32.
29. Kark SL, Gofin J, Abramson JH, Makler A, Mainemer N, Kark E, Epstein LM, Hopp C. Prevalence of selected health characteristics of men: a community health survey in Jerusalem. Isr J Med Sci. 1979;15:732-741.[Medline] [Order article via Infotrieve]
30. Gofin J, Mainemer N, Kark SL, Abramson JH, Hopp C, Epstein LM. Prevalence of selected health characteristics of women and comparisons with men: a community health survey in Jerusalem. Isr J Med Sci. 1981;17:145-159.[Medline] [Order article via Infotrieve]
31.
Tanaka H, Tanana Y, Hayashi H, Ueda Y, Date C, Baba T, Shoji H, Horimoto T, Owada K. Secular trends in mortality for cerebrovascular disease in Japan, 1969 to 1979. Stroke. 1982;13:574-581.
32.
Hachinski W. Decreased incidence and mortality of stroke. Stroke. 1984;15:376-378.
33.
Bonita R, Stewart A, Beaglehole R. International trends in stroke mortality: 1970-1985. Stroke. 1990;21:989-992.
34.
Sacco RL, Hauser WA, Mohr JP, Foulkes MA. One-year outcome after cerebral infarction in the whites, blacks, and Hispanics. Stroke. 1991;22:305-311.
35. Aronovich BD, Treves TA, Bornstein NM, Korczyn AD. Incidence of dementia after first stroke: 3-year follow-up. Third European Stroke Conference, Stockholm, Sweden, 1994.
36. Bornstein N, Karepov V, Aronovich B, Gorbulev A, Treves T, Korczyn AD. Failure of aspirin treatment after stroke. Stroke. 1994;25:275-277.[Abstract]
37. Gur AY, Neufeld MY, Treves TA, Aronovich BD, Bornstein NM, Korczyn AD. EEG as predictor of dementia following first ischemic stroke. Acta Neurol Scand. 1994;90:263-265.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al. Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation' Europace, July 1, 2009; 11(7): 860 - 885. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Samal, S. Greisenegger, E. Auff, W. Lang, and W. Lalouschek The Relation Between Knowledge About Hypertension and Education in Hospitalized Patients With Stroke in Vienna Stroke, April 1, 2007; 38(4): 1304 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Perkins, E. Kahya, C. T. Roque, P. E. Roche, G. C. Newman, and S. Warach Fluid-Attenuated Inversion Recovery and Diffusion- and Perfusion-Weighted MRI Abnormalities in 117 Consecutive Patients With Stroke Symptoms Editorial Comment Stroke, December 1, 2001; 32(12): 2774 - 2781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Koton, N. M. Bornstein, and M. S. Green Population Group Differences in Trends in Stroke Mortality in Israel Stroke, September 1, 2001; 32(9): 1984 - 1988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Bova, J. Chapman, C. Sylantiev, A. D. Korczyn, and N. M. Bornstein The A677V Methylenetetrahydrofolate Reductase Gene Polymorphism and Carotid Atherosclerosis Stroke, October 1, 1999; 30(10): 2180 - 2182. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||